CENIT AG (CSH.DE) Fundamental Analysis & Valuation

FRA:CSH • DE0005407100

6.34 EUR
-0.16 (-2.46%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This CSH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, CSH scores 3 out of 10 in our fundamental rating. CSH was compared to 116 industry peers in the Software industry. CSH has a bad profitability rating. Also its financial health evaluation is rather negative. CSH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. CSH.DE Profitability Analysis

1.1 Basic Checks

  • In the past year CSH has reported negative net income.
  • In the past year CSH had a positive cash flow from operations.
  • CSH had positive earnings in 4 of the past 5 years.
  • CSH had a positive operating cash flow in each of the past 5 years.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

  • CSH has a Return On Assets of -3.14%. This is in the lower half of the industry: CSH underperforms 62.93% of its industry peers.
  • With a Return On Equity value of -12.50%, CSH is not doing good in the industry: 68.10% of the companies in the same industry are doing better.
  • CSH has a Return On Invested Capital (1.04%) which is comparable to the rest of the industry.
  • CSH had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 12.58%.
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROIC 1.04%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • With a Operating Margin value of 0.91%, CSH perfoms like the industry average, outperforming 47.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CSH has declined.
  • Looking at the Gross Margin, with a value of 60.04%, CSH is doing worse than 65.52% of the companies in the same industry.
  • CSH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.91%
PM (TTM) N/A
GM 60.04%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CSH.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSH is destroying value.
  • The number of shares outstanding for CSH remains at a similar level compared to 1 year ago.
  • CSH has about the same amout of shares outstanding than it did 5 years ago.
  • CSH has a worse debt/assets ratio than last year.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.12 indicates that CSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.12, CSH perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
  • The Debt to FCF ratio of CSH is 4.02, which is a neutral value as it means it would take CSH, 4.02 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CSH (4.02) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.10 is on the high side and indicates that CSH has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.10, CSH is doing worse than 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Altman-Z 2.12
ROIC/WACC0.16
WACC6.64%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

  • CSH has a Current Ratio of 1.27. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CSH (1.27) is worse than 61.21% of its industry peers.
  • CSH has a Quick Ratio of 1.27. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
  • CSH's Quick ratio of 1.27 is in line compared to the rest of the industry. CSH outperforms 42.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CSH.DE Growth Analysis

3.1 Past

  • The earnings per share for CSH have decreased strongly by -252.87% in the last year.
  • The Revenue has been growing slightly by 3.58% in the past year.
  • The Revenue has been growing slightly by 3.84% on average over the past years.
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.23% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. CSH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • CSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 44.84 indicates a quite expensive valuation of CSH.
  • CSH's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, CSH is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 44.84
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

  • CSH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSH is cheaper than 87.93% of the companies in the same industry.
  • 97.41% of the companies in the same industry are more expensive than CSH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.66
EV/EBITDA 6.27
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CSH's earnings are expected to grow with 16.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-39.3%
EPS Next 3Y16.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CSH.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.15%, CSH is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.72, CSH pays a better dividend. On top of this CSH pays more dividend than 95.69% of the companies listed in the same industry.
  • CSH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

  • The dividend of CSH decreases each year by -41.82%.
Dividend Growth(5Y)-41.82%
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

More info and screens

Find the best dividend stocksShow peers with best dividend

CSH.DE Fundamentals: All Metrics, Ratios and Statistics

CENIT AG

FRA:CSH (3/3/2026, 7:00:00 PM)

6.34

-0.16 (-2.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06
Earnings (Next)04-09
Inst Owners47.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.07M
Revenue(TTM)210.10M
Net Income(TTM)-4.64M
Analysts90
Price Target13.52 (113.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 44.84
P/S 0.25
P/FCF 4.66
P/OCF 4.08
P/B 1.43
P/tB N/A
EV/EBITDA 6.27
EPS(TTM)-0.55
EYN/A
EPS(NY)0.14
Fwd EY2.23%
FCF(TTM)1.36
FCFY21.48%
OCF(TTM)1.56
OCFY24.53%
SpS25.1
BVpS4.43
TBVpS-2.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -12.5%
ROCE 2.14%
ROIC 1.04%
ROICexc 1.35%
ROICexgc 9.09%
OM 0.91%
PM (TTM) N/A
GM 60.04%
FCFM 5.42%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexgc growth 3Y-6.55%
ROICexgc growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 4.02
Debt/EBITDA 3.27
Cap/Depr 15.31%
Cap/Sales 0.77%
Interest Coverage 0.57
Cash Conversion 104.1%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.12
F-Score5
WACC6.64%
ROIC/WACC0.16
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-252.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.27%
EPS Next Y-228.95%
EPS Next 2Y-39.3%
EPS Next 3Y16.23%
EPS Next 5YN/A
Revenue 1Y (TTM)3.58%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%-3.04%
Revenue Next Year-6.06%
Revenue Next 2Y2.96%
Revenue Next 3Y3.64%
Revenue Next 5Y2.56%
EBIT growth 1Y-77.74%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year29.61%
EBIT Next 3Y44.31%
EBIT Next 5Y27.42%
FCF growth 1Y70.64%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y50.13%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%

CENIT AG / CSH.DE FAQ

What is the fundamental rating for CSH stock?

ChartMill assigns a fundamental rating of 3 / 10 to CSH.DE.


What is the valuation status of CENIT AG (CSH.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to CENIT AG (CSH.DE). This can be considered as Overvalued.


How profitable is CENIT AG (CSH.DE) stock?

CENIT AG (CSH.DE) has a profitability rating of 3 / 10.


What is the earnings growth outlook for CENIT AG?

The Earnings per Share (EPS) of CENIT AG (CSH.DE) is expected to decline by -228.95% in the next year.


Is the dividend of CENIT AG sustainable?

The dividend rating of CENIT AG (CSH.DE) is 6 / 10 and the dividend payout ratio is 0%.